Marshall Wace North America’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $830K | Buy |
+39,503
| New | +$830K | ﹤0.01% | 948 |
|
|
2021
Q2 | – | Sell |
-55,953
| Closed | -$1.63M | – | 1810 |
|
|
2021
Q1 | $1.63M | Buy |
+55,953
| New | +$1.63M | 0.01% | 870 |
|
|
2020
Q3 | – | Sell |
-22,191
| Closed | -$438K | – | 1542 |
|
|
2020
Q2 | $438K | Sell |
22,191
-7,591
| -25% | -$150K | ﹤0.01% | 945 |
|
|
2020
Q1 | $367K | Buy |
+29,782
| New | +$367K | ﹤0.01% | 817 |
|